Eric Andersen, Director Other at MERRIMACK PHARMACEUTICALS INC (MACK), bought 291,773 shares at $3.20 ($903K) on 2020-07-22, disclosed to the SEC on 2020-07-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.04 | 33,192 | $101K | 11.2% |
| 2 | $3.04 | 33,192 | $101K | 11.2% |
| 3 | $3.04 | 63,903 | $194K | 21.5% |
| 4 | $3.04 | 63,903 | $194K | 21.5% |
| 5 | $3.20 | 17,404 | $56K | 6.2% |
| 6 | $3.20 | 62,775 |
| $201K |
| 22.3% |
| 7 | $3.20 | 17,404 | $56K | 6.2% |
| Total | $3.09 avg | 291,773 | $903K | 100% |
| Filing → |
| MACK | BUY | 2023-12-11 | $2.6M | — | Filing → |
| MACK | BUY | 2023-11-14 | $1.3M | — | Filing → |
| MACK | BUY | 2023-08-09 | $2.7M | — | Filing → |